Actionnariat et activité des initiés pour Dare Bioscience, Inc. (DARE): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $0.73 |
| Capitalisation | $11M |
| Bourse | NASDAQ |
| Pays | US |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $35.0M | $7.6M | $6.8M | $4.8M | $4.7M | $51.7M | $34.7M | $10.5M | $15.7M | $24.7M |
| Placements à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Créances | 0 | $284206 | $31037 | $555210 | $460168 | $1.1M | $1.7M | $949211 | $229982 | $573061 |
| Stocks | -$1.8M | $311571 | -$402.7M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $36.8M | $8.3M | $7.2M | $6.4M | $7.0M | $55.3M | $43.0M | $17.5M | $18.4M | $27.1M |
| Immobilisations Corporelles | $668000 | 0 | $9396 | $551811 | $277480 | $242714 | $522833 | $2.0M | $2.5M | $4.4M |
| Goodwill | 0 | $5.2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $37.7M | $14.3M | $7.8M | $7.4M | $7.6M | $55.8M | $43.8M | $21.3M | $22.1M | $32.5M |
| Dettes Fournisseurs | $1.4M | $308219 | $459705 | $1.1M | $1.0M | $2.1M | $2.0M | $3.4M | $1.5M | $1.2M |
| Dette à Court Terme | $8.4M | 0 | 0 | 0 | $367285 | 0 | 0 | 0 | 0 | 0 |
| Passifs Courants | $16.9M | $966653 | $1.1M | $5.6M | $7.7M | $16.1M | $31.6M | $20.5M | $21.6M | $23.7M |
| Dette à Long Terme | $4.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $24.6M | $967045 | $1.1M | $7.0M | $8.7M | $17.1M | $32.7M | $26.3M | $28.1M | $29.6M |
| Réserves | -$200.7M | -$12.2M | -$29.0M | -$44.0M | -$71.4M | -$110.1M | -$141.1M | -$171.2M | -$175.3M | -$188.7M |
| Capitaux Propres | $13.1M | $13.3M | $6.7M | $440826 | -$1.2M | $38.8M | $11.1M | -$5.0M | -$6.0M | $2.8M |
| Dette Totale | $12.8M | 0 | 0 | $800452 | $756841 | $270546 | $488737 | $1.4M | $1.3M | $2.7M |
| Dette Nette | -$22.1M | -$7.6M | -$6.8M | -$4.0M | -$3.9M | -$51.4M | -$34.2M | -$9.1M | -$14.4M | -$22.1M |
| Fonds de Roulement | $19.9M | $7.4M | $6.1M | $831526 | -$676689 | $39.2M | $11.4M | -$2.9M | -$3.2M | $3.4M |
Santé financière
| Dette / Capitaux propres | -12.08 |
| Ratio de liquidité | 0.99 |
Rentabilité
| Rentabilité des capitaux propres | -748.08% |
| Rentabilité du capital investi | -179.10% |
| Rentabilité des actifs | -49.12% |
| Marge brute | -89.45% |
| Marge opérationnelle | -813.38% |
| Marge nette | -804.37% |
Entreprises liées: ADTX · AIMD · ANL · ASBP · ATHA · CTXR · FBLG
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de DARE: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions